February 1, 2012, Washington Technology magazine announced this month that CACI International’s acquisition of Advanced Programs Group (“APG”) was recognized as one of the top three deals contributing to CACI’s recognition as 2011’s Best Dealmaker. Outcome Capital represented APG as its sell-side advisor.
Macroeconomic uncertainty, confusion surrounding the diagnostic regulatory landscape, and the continuing post-COVID-19 pandemic hangover have all contributed to a stagnant, quiet period for mergers and acquisitions in the in vitro diagnostics space in the first half of 2024.
Read MoreOutcome Capital Life Science Market Pulse June 2024 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?